VivoSeq
Other

Gastrointestinal Function

0

Pipeline Programs

1

Active Trials

2

Companies Involved

Gastrointestinal Function is an early-stage landscape with 0 programs across 2 companies. The most active players are Helsinn Therapeutics (U.S.), Inc, Newsoara Biopharma Co., Ltd..

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

9/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

11

clinical trials

Completed6 · 55%
Unknown status3 · 27%
Terminated1 · 9%
Not yet recruiting1 · 9%

Trial Activity

11 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)